An interventional study of Physical Exercise Program in Cerebral Palsy, sponsored by Facultat de ciencies de la Salut Universitat Ramon Llull. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-04-30.
Sponsored by Facultat de ciencies de la Salut Universitat Ramon Llull · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 54 studies in Cerebral Palsy with a site in Spain — 14 open to participants now, 17 under way, 1 of them phase 3. Cerebral Palsy · Spain.
Among the 54 studies in Cerebral Palsy with a site in Spain, this one is the 32nd largest by planned enrollment of the 44 interventional ones that give a count, is one of 7 that started in 2025, is one of 37 with no phase, reaches primary completion later than 10 of the 16 other live ones, and was the 49th registered.
1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.
Browse Cerebral Palsy studies →14 of the 54 studies in Cerebral Palsy with a site in Spain are open now. Recruiting first, the newest first:
University of Valencia · Sites in Spain
Ages 10–18
Fundación para la investigación biomética Hospital Infantil Universitario Niño Jesús · Sites in Spain
Ages 3–8
Universidade da Coruña · Sites in Spain
Ages 3–8
Universidad de Almeria · Sites in Spain
Ages 2–11 · Healthy volunteers
University of Seville · Sites in Spain
Ages 3–12
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
54 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 2 · Phase 3 6
First in 2011; this study’s year is marked. 7 started in 2025.
This study's planned enrollment of 20 is below the median of 34 across 1,434 interventional studies indexed under Cerebral Palsy.
Median enrollment 32 across the 44 interventional studies, 50 across the 10 observational. Of the 33 that completed or were terminated, 4 (12%) have results posted.
This tab as a report to print or save as PDF → With an account.
14 of 54 have an industry lead sponsor. The 10 most frequent:
Facultat de ciencies de la Salut Universitat Ramon Llull is the lead sponsor of 5 studies on the registry; 5 are open to participants now.
Facultat de ciencies de la Salut Universitat Ramon Llull has 1 study filed under Cerebral Palsy — fewer than ten, so there is no comparison to draw.
2 of the studies in Cerebral Palsy with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06438666University of MalagaEffects Obtained at Manual Function After Applying Anodic Transcranial Direct Current Stimulation (tCDS) in Children With Spastic Hemiparetic Cerebral Palsy | 2026-12-23 |
| NCT07745712ABLE Human Motion S.L.Clinical Investigation to Validate the Safety and Performance of the ABLE Kids Device in Pediatric Patients With Neurological Gait Disorders in a Clinical Setting | 2026-12-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 54 studies in Cerebral Palsy with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Cerebral palsy (CP) is a permanent neurological disorder that affects movement and posture, caused by an injury to the developing brain. It may also be accompanied by cognitive, hearing, and speech impairments, as well as epilepsy. Although it is a condition that manifests in childhood, its effects persist throughout life, posing specific challenges in mobility and functionality during adulthood. Although physiotherapy is a key component in the rehabilitation of children with CP and helps adults manage pain and improve motor function, many adults with CP do not receive the treatment they need. Barriers such as financial difficulties, transportation issues, and the lack of physiotherapists specialized in CP affect both access to and the quality of care. Even when physiotherapy is provided, adults with CP are often less satisfied with the services compared to children.The aim of this study is to promote the recovery of motor function in adults with cerebral palsy through sensory stimulation of the lower limbs, as part of an intensive motor rehabilitation program. This program seeks to foster autonomy in movements and transfers, as well as active participation in daily life activities.
Objective: To evaluate the impact of peripheral somatosensory stimulation on motor function in adults with cerebral palsy.
Methods: Experimental, crossover, and randomized. Each participant will serve as their own control and will be assessed under both stimulation (experimental) and non-stimulation (control) conditions.The sample will be one of convenience and will consist of the voluntary participation of 20 adults diagnosed with cerebral palsy who have reduced mobility and are institutionalized at the residence of the Catalan Foundation for Cerebral Palsy (FCPC).The physical exercise program will last for 2 days per week over a period of 12 consecutive weeks, with prior agreement from the center's management and their participation in the study. The 20 participants will be divided into two groups of 10 people. The first group (Group A) will begin the intervention with both the physiotherapy protocol and somatosensory stimulation, while the second group (Group B) will start with the physiotherapy protocol only. At the midpoint of the intervention, in week 6, the groups will switch: Group A will then receive only the physiotherapy protocol, and Group B will begin receiving somatosensory stimulation alongside the physiotherapy protocol. Both groups will continue under these conditions until week 12, marking the end of the intervention.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Group INITIAL will begin the intervention with both the physiotherapy protocol and somatosensory stimulation, At the midpoint of the intervention, in week 6, the groups will switch: Group INITIAL will then receive only the physiotherapy protocol. Both groups will continue under these conditions until week 12, which marks the end of the protocol.
Other: Physical Exercise Program
Group CROSSED will start with the physiotherapy protocol only. At the midpoint of the intervention, in week 6, the groups will switch: Group CROSSED will receive somatosensory stimulation alongside physiotherapy. Both groups will continue under these conditions until week 12, which marks the end of the protocol.
Other: Physical Exercise Program
The physiotherapy protocol has been developed using the GMFCS scale as a reference. Based on this assessment, each patient's level is determined according to their functional motor abilities, limitations, and use of assistive or mobility devices. Each protocol consists of a total of five exercises: two general exercises and three specific exercises focused on the phases of the corresponding transfer and on skills common to all transfers. Rest periods of 2 minutes and 30 seconds are provided between exercises to ensure adequate recovery and a safe progression. The somatosensory stimulation will consist of intermittent mechanical pressure applied to the skin over the neuromuscular motor points of the quadriceps and gastrocnemius muscles. T
Rivermead Mobility Index (RMI)
To evaluate the level of functional mobility, focusing on tasks such as turning over, walking, and climbing stairs. 0-5 points: severely limited mobility. 6-10 points: moderately limited mobility. 11-15 points: mildly limited or good functional mobility.
Time frame: On the third day after the start of the intervention, in week 6, and in week 12.
the Trunk Impairment Scale.
To analyze trunk postural control 0 points: complete absence of trunk control. 1-7 points: severely impaired trunk control. 8-15 points: moderately impaired trunk control. 16-23 points: good trunk control (mild impairment or normal function).
Time frame: On the third day after the start of the intervention, in week 6, and in week 12.
number of repetitions
To evaluate the number of repetitions in the specific exercises of the protocol
Time frame: On the third day after the start of the intervention, in week 6, and in week 12.
The time taken to perform the movement
time required for execution and the completeness of the performance.
Time frame: On the third day after the start of the intervention, in week 6, and in week 12.
Start is estimated for May 2025; primary completion for Jul 2025, 2 months later.
Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 2 months is below that.
Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Facultat de ciencies de la Salut Universitat Ramon Llull